Skip to content

Author

Jun-Yan Li

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Immune checkpoint inhibitors plus chemotherapy for early-stage or locally –advanced triple-negative breast cancer: a systematic review and Bayesian network meta-analysis of randomized trials

Background Immune checkpoint inhibitors (ICIs) combined with chemotherapy have become a cornerstone in managing early and locally advanced triple-negative breast cancer (TNBC). Yet direct comparative evidence on the relative efficacy and safety of different PD-1/PD-L1 agents and treatment strategies—particularly neoadj...

Ying Leng, Jiaqiang Dan, Qiu-Han Heng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.